ANI Pharmaceuticals | Despesas Operacionais





Despesas Operacionais Alterar Data
AbbVie USD 10.81B 13.45B 2025-12
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 146.03M 27.79M 2025-09
Canopy Growth CAD 80.99M 8.64M 2025-09
Eli Lilly USD 10.31B 1.09B 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Heron Therapeutics USD 38.47M 4M 2024-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novartis USD 9.77B 401M 2025-09
Omeros USD 59.16M 20.13M 2024-06
Perrigo USD 1.03B 75.3M 2025-12
Sun Pharmaceuticals INR 111.11B 6.97B 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12


ANI Pharmaceuticals Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.